Lateral alveolar ridge augmentation. Atrophy of edentulous ridge
Conditions
Interventions
Intervention 1: Intervention group: Cenobone/ Cenomembrane.
In this group, Cenobone granules with size of 150 to 1000 microns (Mineralized Cortico Cancellous powder) which have been immersed in nor
Treatment - Surgery
Intervention group: Cenobone/ Cenomembrane.
In this group, Cenobone granules with size of 150 to 1000 microns (Mineralized Cortico Cancellous powder) which have been immersed in normal saline for
Intervention group:Bio Oss/ Bio Gide.
In this group, Bio Oss granules with size of 500 to 1000 microns which have been immersed in normal saline for 30 minutes, are placed in the def
Sponsors
Vice Chancellor for Research and Technology of Babol University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Subjects within the age range of 30 to 50 years, and with sufficient alveolar bone height who have alveolar ridge width of 2 to 4 mm in the area at a distance of 3 mm from the ridge crest are included in the study. Exclusion criteria: Patients with certain systemic conditions which affect healing process are excluded from the survey, including: Uncontrolled diabetes; immune disorders; alcohol addiction; drug abuse; current smoking; pregnancy; immune suppressor or anticoagulant drugs consumption. Additionally, patients with poor compliance; sufferers from active periodontal diseases which complicate oral hygiene; and subjects who don't want to participate in the study are excluded.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lateral ridge augmentation. Timepoint: Six months following grafting. Method of measurement: Radiographic, histologic, and histomorphometric measures. | — |
Secondary
| Measure | Time frame |
|---|---|
| Trabecular thickness. Timepoint: Six months following grafting. Method of measurement: Histomorphometric evaluation six months following grafting.;Number of blood vessels. Timepoint: Six months following grafting. Method of measurement: Evaluation in microscopic fields, six months following grafting.;Extent of inflammation. Timepoint: Six months following grafting. Method of measurement: Evaluation in microscopic fields, six months following grafting.;Foreign body reaction. Timepoint: Six months following grafting. Method of measurement: Evaluation in microscopic fields, six months following grafting.;Bone vitality. Timepoint: Six months following grafting. Method of measurement: Evaluation in microscopic fields, six months following grafting.;Biomaterial/bone contact. Timepoint: Six months following grafting. Method of measurement: Evaluation in microscopic fields, six months following grafting.;Biomaterial/bone radiographic density. Timepoint: Six months following grafting. Method of measurement: CBCT examination, six months following grafting.;Percentage of biomaterial remnants. Timepoint: Six months following grafting. Method of measurement: Histomorphometric evaluation six months following grafting. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Seyed Mohammad Ali Tabatabaei
Babol University of Medical Sciences
Outcome results
None listed